2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 221.370 | 192.928 | 162.356 | 163.681 | 143.026 | 129.850 | 111.802 | 141.383 | 139.718 | 169.521 |
Total Income - EUR | 319.141 | 279.890 | 237.749 | 238.205 | 211.991 | 191.501 | 167.318 | 206.583 | 201.216 | 169.630 |
Total Expenses - EUR | 312.371 | 288.170 | 243.333 | 230.518 | 247.562 | 185.996 | 160.152 | 198.947 | 196.914 | 155.502 |
Gross Profit/Loss - EUR | 6.770 | -8.280 | -5.584 | 7.687 | -35.571 | 5.505 | 7.166 | 7.636 | 4.302 | 14.128 |
Net Profit/Loss - EUR | 5.532 | -8.280 | -5.584 | 6.078 | -37.066 | 4.164 | 6.311 | 6.378 | 3.312 | 12.466 |
Employees | 11 | 10 | 10 | 8 | 6 | 6 | 5 | 5 | 5 | 5 |
Check the financial reports for the company - Pro Medica Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 15.911 | 12.663 | 9.674 | 7.663 | 3.436 | 2.723 | 3.307 | 24.732 | 21.851 | 39.908 |
Current Assets | 163.651 | 145.939 | 136.487 | 123.542 | 50.515 | 48.348 | 50.897 | 50.376 | 40.842 | 41.265 |
Inventories | 135.296 | 119.432 | 110.142 | 96.871 | 38.669 | 35.508 | 35.898 | 36.131 | 25.073 | 27.310 |
Receivables | 27.034 | 25.403 | 24.828 | 24.094 | 9.813 | 12.442 | 12.185 | 12.704 | 11.851 | 12.752 |
Cash | 1.321 | 1.104 | 1.517 | 2.577 | 2.032 | 398 | 2.814 | 1.542 | 3.917 | 1.203 |
Shareholders Funds | 18.314 | 10.186 | 4.499 | 10.500 | -26.758 | -22.075 | -15.346 | -8.628 | -5.342 | 7.140 |
Social Capital | 4.246 | 4.281 | 4.238 | 4.166 | 4.089 | 4.010 | 3.934 | 3.847 | 3.859 | 3.847 |
Debts | 166.263 | 156.625 | 148.009 | 124.538 | 86.594 | 73.157 | 70.197 | 83.344 | 67.949 | 71.708 |
Income in Advance | 3.128 | 2 | 4 | 2.407 | 240 | 1.965 | 740 | 392 | 86 | 2.325 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4778 - 4778" | |||||||||
CAEN Financial Year |
4778
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Pro Medica Srl